Orthropoxvirus Pathogenesis and Vaccines
正痘病毒发病机制和疫苗
基本信息
- 批准号:8073229
- 负责人:
- 金额:$ 2.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimalsAntibodiesAntibody-mediated protectionAntigen PresentationAntigen-Presenting CellsAntigensB-LymphocytesBone MarrowCD8B1 geneCellsCodeDNA VirusesDiseaseDisease ResistanceFrightGene TargetingGenesGrowthHealthHerpesviridaeHistocompatibility Antigens Class IHumanImmune SeraImmune responseImmunityImmunizationImmunocompetentInfectionInfectious EctromeliaIntegration Host FactorsInterferon-alphaInterferonsInterleukin-18LifeMacaca mulattaMemoryModelingMonkeypox virusMorbidity - disease rateMouse Pox VirusMouse StrainsMusMutationOrthologous GeneOrthopoxvirusPathogenesisPathogenicityPathologyProductionProteinsRecombinantsResearch PersonnelResistanceRoleSmallpoxSmallpox VaccineSmallpox VirusesStructural ProteinSubunit VaccinesSurfaceT cell responseT-LymphocyteTestingTimeVaccinationVaccinesVaccinia virusViralViral AntigensViral ProteinsVirionVirusVirus DiseasesVirus ReceptorsWorkbaseenv Gene Productsexperienceinterleukin-18 binding proteinkillingsmortalitymutantnovel strategiespathogenpreventprogramsreceptorresearch studyresponsesuccesstissue cultureweapons
项目摘要
DESCRIPTION (provided by applicant): Orthopoxviruses (OPVs) are large DNA viruses that can be highly lethal to their natural hosts. Smallpox was produced by the human-specific OPV variola virus (VARV) and was eradicated through vaccination with live vaccinia virus (VACV), a mildly pathogenic OPV. Despite this success, we still know little about the reasons for the high pathogenicity of OPVs in their natural hosts and the mechanisms whereby the smallpox vaccine protects. Studying OPVs is important for human health for several reasons: 1) OPVs are common in many animal species and some of these viruses could jump the species barrier and become human pathogens. 2) There is fear that VARV could be used as a weapon. 3) The vaccine based on live VACV is not safe by current standards and killed VACV does not protect. 4) Since the smallpox vaccine is so effective, understanding how it protects may be valuable to develop vaccines to other viruses, including other large DNA viruses such as herpesviruses. In this project our model will be the mouse OPV ectromelia virus (ECTV) that produces mousepox in susceptible strains of mice. A notable feature of OPVs is their expression of secreted immune response modifiers (IRMs). In Specific Aim 1 we will construct and characterize ECTV mutants that do not express specific IRMs. These mutants will be tested and compared with wild type virus for their growth in tissue culture; their ability to spread and induce pathology in immunodeficient and immunocompetent mice; and the strength and type of humoral and cellular immune response that they induce. Any findings should be applicable to the function of the orthologs of those IRMs in other lethal OPV infections such as smallpox in humans. In Specific Aim 2, we will determine whether specific IRMs and structural proteins exposed to the surface of virions are natural targets of protective immune responses and whether they can be used as vaccines. These experiments are important because they will dissect the mechanisms of protective immunity induced by infection and test a novel approach to non-infectious anti-OPV vaccines.
描述(由申请方提供):正痘病毒(OPV)是一种大型DNA病毒,对其天然宿主具有高度致死性。天花由人类特异性OPV天花病毒(VARV)产生,并通过接种活牛痘病毒(VACV)(一种轻度致病性OPV)根除。尽管取得了这一成功,但我们仍然对OPV在其天然宿主中的高致病性的原因以及天花疫苗的保护机制知之甚少。研究OPV对人类健康很重要,原因有几个:1)OPV在许多动物物种中很常见,其中一些病毒可能跨越物种障碍,成为人类病原体。2)人们担心,VARV可能被用作武器。3)根据目前的标准,基于活VACV的疫苗是不安全的,并且灭活VACV不能保护。4)由于天花疫苗是如此有效,了解它如何保护可能是有价值的,以开发疫苗,以其他病毒,包括其他大型DNA病毒,如疱疹病毒。在这个项目中,我们的模型将是小鼠OPV肢脱病病毒(ECTV),在易感小鼠品系中产生鼠痘。OPV的一个显著特征是它们表达分泌的免疫应答调节剂(IRM)。在具体目标1中,我们将构建和表征不表达特异性IRMs的ECTV突变体。将对这些突变体进行检测,并与野生型病毒进行比较,以确定其在组织培养物中的生长情况;其在免疫缺陷和免疫活性小鼠中传播和诱导病理的能力;以及其诱导的体液和细胞免疫应答的强度和类型。任何发现都应适用于这些IRM的直系同源物在其他致命OPV感染(如人类天花)中的功能。在特定目标2中,我们将确定暴露于病毒体表面的特定IRMs和结构蛋白是否是保护性免疫反应的天然靶点,以及它们是否可以用作疫苗。这些实验很重要,因为它们将剖析感染诱导的保护性免疫机制,并测试非感染性抗OPV疫苗的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Luis J Sigal其他文献
Luis J Sigal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Luis J Sigal', 18)}}的其他基金
Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines
mRNA-LNP 疫苗诱导保护性记忆 CD8 T 细胞的机制
- 批准号:
10753981 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Discovering new genes involved in monocyte-mediated protective anti-viral innate immunity through the generation of mice with targeted mutations
通过产生具有靶向突变的小鼠,发现参与单核细胞介导的保护性抗病毒先天免疫的新基因
- 批准号:
10303725 - 财政年份:2021
- 资助金额:
$ 2.13万 - 项目类别:
Discovering new genes involved in monocyte-mediated protective anti-viral innate immunity through the generation of mice with targeted mutations
通过产生具有靶向突变的小鼠,发现参与单核细胞介导的保护性抗病毒先天免疫的新基因
- 批准号:
10416067 - 财政年份:2021
- 资助金额:
$ 2.13万 - 项目类别:
Discovering new genes involved in protective T-cell responses through the generation of mice with targeted mutations
通过培育具有靶向突变的小鼠,发现参与保护性 T 细胞反应的新基因
- 批准号:
10042745 - 财政年份:2020
- 资助金额:
$ 2.13万 - 项目类别:
The Immune Response to Ectromelia Virus in the Draining Lymph Node
引流淋巴结对湿疹病毒的免疫反应
- 批准号:
8891575 - 财政年份:2014
- 资助金额:
$ 2.13万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
8072956 - 财政年份:2010
- 资助金额:
$ 2.13万 - 项目类别:
Immune Mechanisms That Control Ectromelia Virus Infection
控制Ectromelia病毒感染的免疫机制
- 批准号:
7680613 - 财政年份:2009
- 资助金额:
$ 2.13万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 2.13万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 2.13万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 2.13万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 2.13万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)